Aripiprazole and CYP2D6: A retrospective cohort study evaluating the impact of phenotype on metabolic abnormalities.

Meissner BR, Younes F, Massmann A, Weaver M, Petry NJ

Open source

DOI
10.1093/ajhp/zxaf345
Published
2026 May 26
Container
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ajhp/zxaf345,
  title = {Aripiprazole and CYP2D6: A retrospective cohort study evaluating the impact of phenotype on metabolic abnormalities.},
  author = {Meissner BR and Younes F and Massmann A and Weaver M and Petry NJ},
  year = {2026},
  journal = {American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  doi = {10.1093/ajhp/zxaf345},
  url = {https://doi.org/10.1093/ajhp/zxaf345}
}

RIS

TY  - JOUR
TI  - Aripiprazole and CYP2D6: A retrospective cohort study evaluating the impact of phenotype on metabolic abnormalities.
AU  - Meissner BR
AU  - Younes F
AU  - Massmann A
AU  - Weaver M
AU  - Petry NJ
PY  - 2026
JO  - American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
DO  - 10.1093/ajhp/zxaf345
UR  - https://doi.org/10.1093/ajhp/zxaf345
ER  - 

APA

BR, M., F, Y., A, M., M, W., & NJ, P. (2026). Aripiprazole and CYP2D6: A retrospective cohort study evaluating the impact of phenotype on metabolic abnormalities.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. https://doi.org/10.1093/ajhp/zxaf345

Source records